Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12281136
Crystalline forms of a CD73 inhibitor and uses thereof
granted -
US 12280063
Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease
granted -
US 12281111
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
granted -
US 12281122
PI3K inhibitors
granted -
CN 119857078
PARP inhibitor child preparation and preparation process thereof
granted -
US 12281173
Methods for treating patients with hyperlipidemia by administering a PCSK9 inhibitor in combination with an ANGPTL3 inhibitor
granted -
TW 202515875
Solid forms comprising a B-RAF kinase dimer inhibitor, methods of preparation, and uses therefor
granted -
US 12269805
Inhibitors of platelet function and methods for use of the same
granted -
US 12269820
Piperazine substituted indazole compounds as inhibitors of PARG
granted -
US 12268673
Anhydrous compositions of mTOR inhibitors and methods of use
granted -
US 12268694
Combination pharmaceutical agents as RSV inhibitors
granted -
US 12264158
Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
granted -
US 12264149
Indazole compounds as kinase inhibitors
granted -
US 12263156
Use of small molecule inhibitors of the BfrB:Bfd interaction in biofilms
granted -
US 12263165
Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
granted -
US 12264169
Heteroaryl inhibitors of PDE4
granted -
TW 202513047
KAT6 inhibitors
granted -
US 12264167
Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors
granted -
US 12263173
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
granted -
US 12258367
Glucoside derivative that acts as SGLT1 inhibitor and application thereof
granted -
US 12251387
Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors
granted -
US 12252493
Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer
granted -
US 12252497
Ras inhibitors
granted -
US 12251370
Small molecule inhibitors of the BfrB:Bfd interaction
granted